Presentation previews · Artwork labels are not verified filling specifications. Purchasing is not available.

AEVIA MED / VIALS
IGF-1 LR3
IGF-I analogue researched in growth-signalling models; supplied identity is held.
FOR LABORATORY RESEARCH USE ONLY
NOT FOR HUMAN OR ANIMAL USE.
Do not inject, ingest or otherwise administer to humans or animals.
Research-use policy →Price
Price to confirm
Presentation status
Supplied visual concept. The printed amount is an artwork reference, not confirmation of AEVIA filling, formulation, physical state or use. It is not an application dose.
Research-only intended use
This product is intended solely for laboratory research conducted by appropriately trained personnel in suitable laboratory facilities. It must not be used in or on humans or animals, including by injection, ingestion or topical application.
It is not supplied for clinical, diagnostic, therapeutic, veterinary, cosmetic, food or supplement use. References to published studies describe research context only; they are not instructions or recommendations to use this product in people or animals.
The quantity stated on the container is the total supplied content, not an administration dose. Consult the applicable product documentation and safety data before laboratory handling. A product or batch record match does not establish suitability for human or animal use.
Research-use policy →Compound identity and research context · Separate from the exact product specification
What it is
Long R3 IGF-I is an analogue used in experimental growth-signalling research.
Biological target / research area
IGF-related cell growth and muscle biology in experimental models.
What the research examined
Evidence context: preclinical with safety signal
A tumour-bearing mouse study investigated muscle wasting and also reported accelerated tumour growth.
Evidence limitations
This does not support healthy bodybuilding use. Exact analogue identity and product-specific safety must be resolved before any offer or benefits claim.
IGF-1 LR3 · 1 mg: this printed quantity identifies the artwork presentation. It is not a verified filling specification or an application dose.
Selected references
- LR3 IGF-I in tumour-bearing mice and cancer-associated muscle wasting (2019) ↗ · Reviewed 14/10/2026
Composition & specification
Verified product specifications and release documentation are pending. No dosing, preparation or administration instructions are provided.
The identity shown on this artwork is still under review. This presentation is excluded from kit selection.
Storage, safety & batch information
Product-specific storage, expiry and safety documentation must be confirmed for the exact released presentation. Use the exact-presentation batch reference lookup in the product guide. A record match does not authenticate physical contents.